The Oncology Institute Inc (TOI)
1.15
+0.03
(+2.68%)
USD |
NASDAQ |
May 02, 16:00
1.10
-0.05
(-4.35%)
After-Hours: 20:00
Oncology Institute Enterprise Value: 89.43M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 89.43M |
| May 01, 2024 | 87.20M |
| April 30, 2024 | 82.74M |
| April 29, 2024 | 84.97M |
| April 26, 2024 | 89.43M |
| April 25, 2024 | 91.66M |
| April 24, 2024 | 93.15M |
| April 23, 2024 | 91.66M |
| April 22, 2024 | 87.95M |
| April 19, 2024 | 92.40M |
| April 18, 2024 | 95.38M |
| April 17, 2024 | 90.92M |
| April 16, 2024 | 90.17M |
| April 15, 2024 | 92.40M |
| April 12, 2024 | 99.09M |
| April 11, 2024 | 106.52M |
| April 10, 2024 | 108.75M |
| April 09, 2024 | 118.41M |
| April 08, 2024 | 122.13M |
| April 05, 2024 | 115.44M |
| April 04, 2024 | 115.44M |
| April 03, 2024 | 114.70M |
| April 02, 2024 | 118.41M |
| April 01, 2024 | 119.90M |
| March 28, 2024 | 121.39M |
| Date | Value |
|---|---|
| March 27, 2024 | 140.71M |
| March 26, 2024 | 129.56M |
| March 25, 2024 | 119.90M |
| March 22, 2024 | 105.78M |
| March 21, 2024 | 105.04M |
| March 20, 2024 | 108.38M |
| March 19, 2024 | 113.95M |
| March 18, 2024 | 124.09M |
| March 15, 2024 | 128.54M |
| March 14, 2024 | 143.36M |
| March 13, 2024 | 135.95M |
| March 12, 2024 | 135.21M |
| March 11, 2024 | 126.31M |
| March 08, 2024 | 128.54M |
| March 07, 2024 | 130.76M |
| March 06, 2024 | 124.83M |
| March 05, 2024 | 126.31M |
| March 04, 2024 | 128.54M |
| March 01, 2024 | 130.76M |
| February 29, 2024 | 143.36M |
| February 28, 2024 | 141.14M |
| February 27, 2024 | 145.59M |
| February 26, 2024 | 144.11M |
| February 23, 2024 | 140.40M |
| February 22, 2024 | 143.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
42.67M
Minimum
Mar 17 2023
903.60M
Maximum
Dec 28 2021
235.15M
Average
145.83M
Median
Enterprise Value Benchmarks
| Encompass Health Corp | 11.59B |
| Pediatrix Medical Group Inc | 1.213B |
| US Physical Therapy Inc | 1.732B |
| US Neurosurgical Holding Inc | 9.114M |
| American Oncology Network Inc | 289.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.75M |
| Revenue (Quarterly) | 85.79M |
| Total Expenses (Quarterly) | 101.08M |
| EPS Diluted (Quarterly) | -0.21 |
| Gross Profit Margin (Quarterly) | 16.76% |
| Profit Margin (Quarterly) | -21.86% |
| Earnings Yield | -80.00% |
| Normalized Earnings Yield | -65.20 |